News

Funding an unconventional approach to fighting cancer that emphasizes the integration of diverse scientific disciplines, the U.S. Department of Defense has awarded $3.2 million to establish the Convergent Science Cancer Consortium (CSCC), led by Dean’s Professor of Biological Sciences Peter Kuhn at the USC Dornsife

In a rapid communication published in the journal Genes & Diseases, has shed light on the role of the Wnt signaling pathway in influencing the immune response of colorectal cancer (CRC) patients. Researchers from Nankai University discovered that abnormalities in this pathway can affect a

Ultrafast laser technology continues to surprise. While research in this field may seem rather abstract at first glance, it very often leads to concrete applications. This is particularly true in healthcare, where the technology can be used to treat certain cancers. Credit: INRS Ultrafast laser

Research published today in Nature sheds light on a small part of the so-called “dark genome” — the 98 per cent of the human genome whose biological function is largely not known.  Credit: John Ulan Research published today in Nature sheds light on a small

Long-term use of analgesics such as morphine leads to “tolerance” that reduces drug efficacy. In such cases, dose escalation may be required to achieve the same analgesic effects. The key molecular mechanism of morphine tolerance is its inefficiency in inducing mu-opioid receptor (MOR) endocytosis. Unfortunately,

Antibodies are an important tool in the human immune system’s arsenal against disease. They attach to bacteria, viruses, fungi, or toxins, marking them for destruction or removal from the body. Credit: Kinga Lubowiecka / EMBL Antibodies are an important tool in the human immune system’s

HBV-related HCC poses a significant global health challenge, characterized by its cellular diversity and complex tumor immune microenvironment. The increasing unmet need in HBV-HCC treatment drives to deeper understand the role of the intricate immune microenvironment, tumor cell plasticity and dynamics of tumor evolution in

Blood cells reveal tumours in the body. Researchers at the Paul Scherrer Institute achieve an advance with the development of a test for early diagnosis of cancer. Credit: PAUL SCHERRER INSTITUTE/MARKUS FISCHER Blood cells reveal tumours in the body. Researchers at the Paul Scherrer Institute

Mice with human immune cells are a new way of testing anti-cancer drugs targeting the immune system in pre-clinical studies. Using their new model, the Kobe University research team successfully tested a new therapeutic approach that blindfolds immune cells to the body’s self-recognition system and

SALT LAKE CITY – Researchers at Huntsman Cancer Institute at the University of Utah (the U) discovered that the level of blood and immune cells in mouse model offspring would fluctuate based on the amount of folic acid consumed by their mothers during pregnancy. Credit: